title: [Effects of intervention embolization therapy and intratumor injection with hardener on head and neck gigantic hemangioma].
abstract: OBJECTIVE
  The goal of this study is to present our experience of transarterial embolization and intratumor injection for the treatment of gigantic hemangioma of the head, face, and neck.
  
  
  METHODS
  From 2001 to 2003, 3 patients with gigantic hemangioma were selected to get digital subtraction angiography (DSA) and transarterial embolization and intratumor injection successfully.
  
  
  RESULTS
  Angiography after embolization showed almost complete obliteration of hemangioma. There were no serious complications such as embolism to other organs and necrosis of a large area in the embolized tissue. Only slight swelling and pain in the embolized area were present. And gradually disappeared by expect and treatment. No recurrence of the symptoms was occurred in a follow-up evaluation of 6- 24 months.
  
  
  CONCLUSIONS
  Using of DSA. transarterial embolization and intratumor injection showed an excellent clinic effect on treatment of hemangioma, reducing the recurrence of the symptoms.
authors.affiliation: Department of Otorhinolaryngology, Second Hospital of Xi'an Jiaotong University, Xi'an 710004, China. zhangwen0606@sina100.com
authors.forename: Wen
authors.initials: W
authors.lastname: Zhang
authors.forename: Xiaotoing
authors.initials: X
authors.lastname: Zhang
authors.forename: Xiaoyong
authors.initials: X
authors.lastname: Ren
authors.forename: Jianmin
authors.initials: J
authors.lastname: Liang
authors.forename: Xianghong
authors.initials: X
authors.lastname: Zhang
authors.forename: Baoshu
authors.initials: B
authors.lastname: Li
authors.forename: Min
authors.initials: M
authors.lastname: Xu
authors.forename: Quanan
authors.initials: Q
authors.lastname: Zhang
mesh_terms: D000328:Adult; D015901:Angiography, Digital Subtraction; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006391:Hemangioma / Q000628:therapy*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D015911:Sclerotherapy